THE NATIONAL KIDNEY FOUNDATION, INC.
JOURNAL PUBLISHING AGREEMENT
PLEASE PROVIDE US WITH THE FOLLOWING INFORMATION, REVIEW OUR POLICIES AND THE PUBLISHING
AGREEMENT, AND INDICATE YOUR ACCEPTANCE OF THE TERMS.
Article entitled:
Manuscript #:
Corresponding author:
To be published in the journal:
AJKD-D-
American Journal of Kidney Diseases
YOUR STATUS
I am the sole author of the manuscript
Please indicate if any of the below also apply to you:
I am a UK Government employee electing to transfer copyright
I am a UK, Canadian, or Australian Government employee and Crown Copyright is claimed
I am a US Government employee and there is no copyright to transfer
I am one author signing on behalf of all co-authors of the manuscript
Please indicate if any of the below also apply to you and your co-authors:
We are all US Government employees and there is no copyright to transfer
We are all UK Government employees electing to transfer copyright
We are all UK, Canadian, or Australian Government employees and Crown Copyright is claimed
The article is a ‘work made for hire’ and I am signing as an authorized representative of my employer
Please indicate if any of the below also apply to you:
The article is authored by US Government employees and there is no copyright to transfer
The article is authored by UK, Canadian, or Australian Government employees and Crown Copyright is claimed
FUNDING
The underlying research reported in the article was funded by the US National Institutes of Health
Articles accepted for publication in AJKD from authors who have indicated that the underlying research reported in their articles was
supported by an NIH grant will be sent by Elsevier to PMC for public access posting 12 months after final publication. The version of the
article provided by Elsevier will include peer-review comments incorporated by the author into the article.
The underlying research reported in the article was performed by a Howard Hughes Medical Institute investigator
Articles accepted for publication in AJKD from authors who have indicated that they are HHMI investigators will be sent by Elsevier to
PMC for public access posting 6 months after final publication. The version of the article provided by Elsevier will include peer- review
comments incorporated by the author into the article.
The underlying research reported in the article was supported by one of the funding bodies below:
Arthritis Research Campaign
British Heart Foundation
Department of Health (UK)
Medical Research Council (UK)
Wellcome Trust
Elsevier has agreements with these funding bodies to allow authors who publish in Elsevier journals to comply with manuscript archiving
requirements, as specified as conditions of researcher grant awards. Please visit: Elsevier Funding Body Agreements & Policies
(http://www.elsevier.com/wps/find/authorsview.authors/fundingbodyagreements) to download and submit an Author Sponsorship Form.
No funding or funding from a source other than the above
Please check one or more of the above boxes (as appropriate) and then sign and date the document in black ink.
Signed:_______________________________________
Name printed: ___________________________________________
Title and Company (if employer representative) : _________________________________________________________
Date: _______________________________________
Please return the completed and signed original of this form (this page only) by mail or fax, or by e-mailing a scanned copy of the signed
original (retaining a copy for your files) to:
Fax:
E-mail:
617-636-0598
AJKD@tuftsmedicalcenter.org
Postal Mail:
AJKD Editorial Office / Attn: N. Dorman
Tufts Medical Center, Box #391
750 Washington St.
Boston, MA 02111
THE PUBLISHING AGREEMENT
Assignment of publishing rights
I hereby assign to The National Kidney Foundation, Inc. the copyright in the manuscript identified above (government authors not electing to
transfer agree to assign a non-exclusive licence) and any supplemental tables, illustrations or other information submitted therewith that are intended
for publication as part of or as a supplement to the manuscript (the “Article”) in all forms and media (whether now known or hereafter developed),
throughout the world, in all languages, for the full term of copyright, effective when and if the article is accepted for publication. This transfer
includes the right to provide the Article in electronic and online forms and systems.
Retention of Rights for Scholarly Purposes (see Definitions below)
I understand that I retain or am hereby granted (without the need to obtain further permission) rights to use certain versions of the Article for certain
scholarly purposes, as described and defined below (“Retained Rights”), and that no rights in patents, trademarks or other intellectual property rights
are transferred to the journal.
The Retained Rights include the right to use the Pre-print or Accepted Authors Manuscript for Personal Use, Internal Institutional Use and for
Scholarly Posting; and the Published Journal Article for Personal Use and Internal Institutional Use. No versions of the Article can be used for
Commercial Purposes.
Author Warranties/Ethics and Disclosure
I affirm the Author Warranties noted below, and confirm that I have reviewed and complied with the Instructions to Authors and the AJKD editorial
policies. For further information see www.ajkd.org.
Author warranties

The article I have submitted to the journal for review is original, has been written by the stated authors and has not been published elsewhere.

The article is not currently being considered for publication by any other journal and will not be submitted for such review while under review
by this journal.

The article contains no libellous or other unlawful statements and does not contain any materials that violate any personal or proprietary rights
of any other person or entity.

I have obtained written permission from copyright owners for any excerpts from copyrighted works that are included and have credited the
sources in my article.

If the article was prepared jointly with other authors, I have informed the co-author(s) of the terms of this publishing agreement and that I am
signing on their behalf as their agent, and I am authorized to do so.
Funding Agency Requirements and Other Policies
I have also been made aware of the journal’s policies with respect to funding agency requirements such as the NIH Public Access Policy.
DEFINITIONS
Accepted Authors Manuscript (“AAM”): Author’s version of the manuscript of a paper that has been accepted for publication and which may include any authorincorporated changes suggested through the peer review process. AAMs should not include however other publisher value added contributions such as formatting and
pagination, and should include the Appropriate Bibliographic Citation and a link to the final publication (generally through the relevant DOI).
Appropriate Bibliographic Citation: Authors posting Accepted Authors Manuscript online may later add a citation for the Published Journal Article indicating that
the paper was subsequently published, and may mention the journal title provided they add the following text at the beginning of the document:
“NOTICE: this is the author’s version of a work that was accepted for publication in <Journal title>. Changes resulting from the publishing process, such as peer
review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this
work since it was submitted for publication. A definitive version was subsequently published in PUBLICATION, [VOL#, ISSUE#, (DATE)] DOI#”
Commercial Purposes: The use or posting of articles for commercial gain including the posting by companies or their employee-authored works for use by customers
of such companies (e.g. pharmaceutical companies and physician-prescribers); commercial exploitation such as directly associating advertising with such postings; the
charging of fees for document delivery or access; or the systematic distribution to others via e-mail lists or list servers (to parties other than known colleagues), whether
for a fee or for free.
Internal Institutional Use: Use by the author’s institution for classroom teaching at the institution (including distribution of copies, paper or electronic, and use in
coursepacks and courseware programs) and posting on secure Intranet sites for scholarly purposes.
Personal Use: Use by an author in the author’s classroom teaching (including distribution of copies, paper or electronic), distribution of copies to research colleagues
for their personal use, use in a subsequent compilation of the author’s works, inclusion in a thesis or dissertation, preparation of other derivative works such as
extending the article to book-length form, or otherwise using or re-using portions or excerpts in other works (with full acknowledgment of the original publication of
the article).
Pre-print: Author’s own write-up of research results and analysis that has not been refereed, nor had any other value added to it by a publisher (such as formatting,
copy editing, and the like).
Published Journal Article (“PJA”): The definitive final record of published research that appears or will appear in the journal and embodies all value-adding
publisher activities including formatting and pagination.
Scholarly Posting: Postings on open Web sites operated by the author or the author’s institution for scholarly purposes, or (in connection with Pre-prints) pre-print
servers, provided there is no Commercial Purpose involved. Deposit in or posting to Special Subject Repositories (such as PubMed Central) is permitted only under
specific agreements between Elsevier and the repository and only consistent with Elsevier’s policies concerning such repositories. If the author wishes to refer to the
journal in connection with such posting, the Appropriate Bibliographic Citation should be used.
Special Subject Repositories: Certain repositories such as PubMed Central (“PMC”) are authorized under special arrangement with Elsevier to process and post
certain articles such as those funded by the National Institutes of Health under its Public Access Policy, effective April 7, 2008 (see elsevier.com for more detail on our
policy). The NIH’s Public Access Policy requires that NIH-funded authors submit to PubMed Central (PMC), or have submitted on their behalf, their peer-reviewed
author manuscripts, to appear on PMC no later than 12 months after final publication. Articles accepted for publication in AJKD from authors who have indicated that
the underlying research reported in their articles was supported by an NIH grant will be sent by Elsevier to PMC. Elsevier will send to PMC the final peer-reviewed
manuscript that reflects any author-agreed changes made in response to peer-review comments and was received by Elsevier’s production department. Elsevier will
authorize the author manuscript’s public access posting 12 months after final publication. Following the deposit by Elsevier, authors will receive further
communications from the NIH with respect to the submission.